Effects of Linomide on growth and metastasis of human gastric cancer in nude mice

陶厚权,林言箴,尹浩然,顾琴龙,朱正纲,姚明

DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.1998.03.107

1998-01-01

Abstract:Objective:To elucidate the effect of angiogenesis inhibitor, Linomide, on the tumor growth and metastasis in nude mice implanted with human gastric cancer.Methods:Patient-like metastatic model of gastric cancer was established by orthotopic implantation of intact tumor tissue into gastric wall of nude mice. Linomide (0, 80 and 160 mg/kg body weight) was given p. o. every day after implantation. The mice were sacrificed later 10 weeks, and the tumor size and tumor metastasis were detected. The microvessel counts were investigated by immunohistochemical staining with a monoclonal antibody against F-Ⅷ Rag.Results:There was a significant difference in the size of the implanted tumors (control group, 1.36±0.81cm 3 versus Linomide treated group, 0.84±0.51cm 3 and 0.62±0.35cm 3, P<0.05 and 0.01, respectively). An antimetastatic effect of Linomide was clearly demonstrated in a dose-dependent manner. In the mice given 80 mg/kg Linomide, liver metastasis developed in 4 of 10 cases. In the 160 mg/kg group, metastasis developed in only 1 of 10 mice, while metastasis developed in 19 of 28 mice of the control group ( P<0.05 and 0.01, respectively). The number of metastatic foci was also significantly less in the treated group. Furthermore, the microvessel counts in tumors of treated mice was reduced to 33%~42% of that in controls ( P<0.01) . Conclusion:Linomide has a strong inhibitory activity against in vivo tumor growth and metastasis of gastric cancer.